Lotz Christopher L. 4
4 · Qualigen Therapeutics, Inc. · Filed Apr 19, 2021
Insider Transaction Report
Form 4
Lotz Christopher L.
VP of Finance, CFO.
Transactions
- Purchase
Common Stock
2021-04-16$1.86/sh+2,700$5,022→ 12,541 total
4 · Qualigen Therapeutics, Inc. · Filed Apr 19, 2021
Common Stock